Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

NCT04620603 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Malignant Melanoma
Renal Cell Cancer
Urothelial Cancer of Renal Pelvis

Interventions

RADIATION: Low Dose Rate Brachytherapy (LDR)
DRUG: Standard-of-Care Immunotherapy

Sponsor

Case Comprehensive Cancer Center